Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches
Nishant Patel, Jason Woo, Michael A. Liss, Kerrin L. Palazzi, J. Michael Randall, Reza Mehrazin, Ramzi Jabaji, Hossein S. Mirheydar, Kyle Gillis, Hak J. Lee, Anthony L. Patterson, Christopher J. Kane, Frederick Millard, Ithaar H. Derweesh
Producción científica: Article › revisión exhaustiva
Profundice en los temas de investigación de 'Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches'. En conjunto forman una huella única.